Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Carna Bio. Signs License Agreement with JHSF for Anticancer Drug Screening Methods
August 2, 2010
- Korosho to Introduce Japanese Version of ACIP
August 2, 2010
- Survey Conducted by OPA Shows Good Compliance
August 2, 2010
- 29 Drugs Including Forteo, Orencia Approved
August 2, 2010
- Livalo to Be Approved in 16 European Countries
August 2, 2010
- Conduct KRAS Gene Testing before First-Line Treatment for CRC: Dr Yoshino of NCC
August 2, 2010
- Celgene Launches Revlimid, Lenadex for Multiple Myeloma
August 2, 2010
- T-DM1 Applied to FDA for Advanced HER2-Positive Breast Cancer: Roche
August 2, 2010
- Hokunalin Tape Offers Benefits to Patients with Asthma, CVA: Dr Ohbayashi
August 2, 2010
- Prices May Not Be Settled by End of October: President Tajiri of MSNW
August 2, 2010
- Sprycel to Receive FDA Priority Review for Chronic CML in Adults
August 2, 2010
- Prof. Kawabuchi Calls For a Vaccine Law
August 2, 2010
- Asahi Kasei Pharma to Apply for PTH Inj within 2010
August 2, 2010
- FDA Orders GSK to Stop New Patient Enrollment for TIDE Trial
August 2, 2010
- Korosho Underestimates Drug Expenditures: Hodanren
August 2, 2010
- Ranbaxy to Market Levofloxacin in Romania, South Africa
August 2, 2010
- Developed vs Emerging Countries Fail to Agree on Benefit Sharing
August 2, 2010
- MedPeer to Provide “Voices of Doctors”to Drug Companies
August 2, 2010
- 3 FDCs to Gain 50% Share in HIV Drug Market in 2019: Datamonitor
August 2, 2010
- 46.4% of NPhA Members Not Receiving Premium for Generics Dispensing System
August 2, 2010
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…